Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (results from the EXPLORER study)

収録刊行物

• Am J Cardiol

  Am J Cardiol 99 673-680, 2007